Covered recipient · General Payments record
BETH A BARTHOLOMEW
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$2,450.89
- Reported across 152 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $337.67 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CVRx Inc. | $175.74 | 9 |
| Abbott Laboratories | $56.57 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $37.88 | 2 |
| Janssen Pharmaceuticals, Inc | $32.14 | 2 |
| Medtronic, Inc. | $18.12 | 1 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $17.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $56.57 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125168306 | CMS |
| CVRx, Inc. | $21.76 | 01/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127676078 | CMS |
| CVRx, Inc. | $27.14 | 01/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127676080 | CMS |
| CVRx, Inc. | $5.69 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127676082 | CMS |
| CVRx, Inc. | $21.77 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127676084 | CMS |
| CVRx, Inc. | $7.36 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127676086 | CMS |
| CVRx, Inc. | $14.78 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127676088 | CMS |
| CVRx, Inc. | $30.64 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127676090 | CMS |
| CVRx, Inc. | $23.30 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127676092 | CMS |
| CVRx, Inc. | $23.30 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127676094 | CMS |
| Janssen Pharmaceuticals, Inc | $14.34 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077957280 | CMS |
| Janssen Pharmaceuticals, Inc | $17.80 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077957106 | CMS |
| Medtronic, Inc. | $18.12 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119415194 | CMS |
| Novartis Pharmaceuticals Corporation | $18.32 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086706307 | CMS |
| Novartis Pharmaceuticals Corporation | $19.56 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086706313 | CMS |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $17.22 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1080572403 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.